
Dolby Laboratories: stock overview
Price
$63.61
November 13, 2026Market cap $6.1B
What Ploutos Investor adds for Dolby Laboratories
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from FY2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has risen 23% since Jul 30, 2026, when the 10-Q these figures come from was filed ($51.78 then, $63.61 on Nov 13, 2026). The figures date from before that move.10-Q
- The latest annual figures the company filed are for 2025, more than a year ago. Newer ones may be late.
In short
Dolby Laboratories had revenue of $1.4B over the last 12 months and net income of $226M, a net margin of 16.7%. Revenue grew by 3.0% a year on average over the last 5 years. At $63.61 the shares trade at a P/E of 27.0, against a median of 31.1 over the last 5 fiscal years. It holds more cash than debt, by $670M. It pays a dividend yielding 2.26%.
From its SEC filings (latest fiscal year to September 26, 2025) and the price of November 13, 2026.
Its SEC filings- Market cap
- $6.1B
- 95.87M shares
- P/E
- 27.0
- Today27.0Median31.1
- Revenue, 12 months
- $1.4B
- +3.0% a year over 5 years
- Net margin
- 16.7%
- FY2025: 18.9%, above 62% of its industry
Worth knowing
What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.
3 fiscal years in figures
Each fiscal year's figures as the company filed them, and the share price at its end.
+1.9% a year over 2 years
Fiscal years in figures
DLB's revenue, profit, cash flow and dividend with each year-end price, from FY2009 to FY2022, 14 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
Key figures
The company's current figures in five groups. Each term is explained behind its ⓘ.
Valuation
- Market cap 3-year median: $7.2B
- $6.1B
- Enterprise value
- $5.4B
- P/E 3-year median: 28.1
- 27.0
- EV / EBIT
- 22.7
- EV / Revenue
- 4.0
- P/B 3-year median: 2.9
- 2.4
- FCF yield 3-year median: 4.4%
- 6.4%
- Earnings yield 3-year median: 3.6%
- 3.7%
Profitability
- Gross margin
- 87.6%
- Operating margin
- 17.7%
- Net margin 3-year median: 18.9%
- 16.7%
- ROIC
- 7.6%
- ROIC, 5-year average
- 8.2%
- ROE
- 8.7%
Growth
- Revenue, yearly change
- +5.9%
- EPS, yearly change
- -2.6%
- FCF, yearly change
- +46.6%
- Revenue, average a year
- +3.0%
- EPS, average a year
- +3.1%
The yearly change compares FY2025 with FY2024.
Balance sheet
- Cash
- $670M
- Total debt
- $47M
- Of which operating leases
- $47M
- Net cash
- $670M
- Net debt / EBITDA
- -2.1x
- Interest cover
- –
- Current ratio
- 3.19
Balance sheet of June 26, 2026.
Returns to shareholders
- Dividend yield 3-year median: 1.6%
- 2.26%
- Buybacks
- 2.05%
- Total returned
- 4.31%
- Shares, yearly change
- +0.3%
Against its industry
Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 67).
Gross margin
88.1%
Above 97% of the 16 companies in its industry, and 99% of all.
Operating margin
19.6%
Above 41% of the 106 companies in its industry, and 82% of all.
Net margin
18.9%
Above 62% of the 212 companies in its industry, and 81% of all.
ROE
9.8%
Above 78% of the 204 companies in its industry, and 60% of all.
ROA
8.0%
Above 95% of the 221 companies in its industry, and 83% of all.
Revenue growth
5.9%
Above 62% of the 211 companies in its industry, and 49% of all.
From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.
The company at the SEC
How it is registered and when its fiscal year ends.
- Name at the SEC
- Dolby Laboratories, Inc.
- CIK
- 1308547
- Exchange
- NYSE
- Industry (SIC)
- 6794 · Patent Owners & Lessors
- Fiscal year ends
- September 27
- Latest annual report
- September 26, 2025
- Reporting currency
- USD
- Shares
- 95.87M
Other companies: Real estate
The largest companies of the same sector, each with its own page.
- WELLWelltower+0,00%Compare with DLB
- PLDPrologis+0,00%Compare with DLB
- EQIXEquinix+0,00%Compare with DLB
- AMTAmerican Tower+0,00%Compare with DLB
- SPGSimon Property+0,00%Compare with DLB
- DLRDigital Realty Trust+0,00%Compare with DLB
- ORealty Income+0,00%Compare with DLB
- PSAPublic Storage+0,00%Compare with DLB
The full analysis
What do Dolby Laboratories's filings show?
These are Dolby Laboratories's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
What is DLB's market cap?
Dolby Laboratories's market cap is $6.1B, at a price of $63.61 on November 13, 2026 and 95.87M shares.
What is DLB's P/E?
DLB's P/E is 27.0, on earnings per share of $2.35 over the last 12 months. The median over the last 5 fiscal years was 31.1.
How much revenue does DLB have?
Dolby Laboratories had revenue of $1.4B over the last 12 months. Over the last 5 years it changed by +3.0% a year on average.
Does DLB pay a dividend?
Yes. Dolby Laboratories paid $1.44 per share over the last 12 months, a yield of 2.26% at today's price. All the figures are in the Dividend section.
Where do the figures come from?
From Dolby Laboratories's SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.